Literature DB >> 9839348

Analysis of repeated markers used to predict progression of cancer.

B Emir1, S Wieand, J Q Su, S Cha.   

Abstract

We consider methods for evaluating repeated markers to be used as a substitute for a clinical examination or to predict an outcome, in our case progression of breast cancer. We propose a definition of specificity and sensitivity for this setting and describe non-parametric estimators for these parameters. We then derive the theory required to obtain confidence intervals for the specificity and sensitivity of a marker and to define an asymptotically normal statistic for comparing the sensitivities of two markers at a fixed specificity. The theory allows for correlations introduced by the fact that markers may be obtained from the same patient at multiple visits and that both markers being compared may be obtained from the same patient. The work allows for an approach that complements the frequently used time dependent Cox model, which we believe, will facilitate clinical interpretation of marker data.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839348     DOI: 10.1002/(sici)1097-0258(19981130)17:22<2563::aid-sim952>3.0.co;2-o

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Prediction based classification for longitudinal biomarkers.

Authors:  A S Foulkes; L Azzoni; X Li; M A Johnson; C Smith; K Mounzer; L J Montaner
Journal:  Ann Appl Stat       Date:  2010-09       Impact factor: 2.083

2.  Evaluating the ROC performance of markers for future events.

Authors:  Margaret S Pepe; Yingye Zheng; Yuying Jin; Ying Huang; Chirag R Parikh; Wayne C Levy
Journal:  Lifetime Data Anal       Date:  2007-12-07       Impact factor: 1.588

3.  A Novel Network Model for Molecular Prognosis.

Authors:  Ying-Wooi Wan; Swetha Bose; James Denvir; Nancy Lan Guo
Journal:  ACM Int Conf Bioinform Comput Biol (2010)       Date:  2010

4.  A Unified Approach to Nonparametric Comparison of Receiver Operating Characteristic Curves for Longitudinal and Clustered Data.

Authors:  Gang Li; Kefei Zhou
Journal:  J Am Stat Assoc       Date:  2008       Impact factor: 5.033

5.  Cell-Free DNA and Active Rejection in Kidney Allografts.

Authors:  Roy D Bloom; Jonathan S Bromberg; Emilio D Poggio; Suphamai Bunnapradist; Anthony J Langone; Puneet Sood; Arthur J Matas; Shikha Mehta; Roslyn B Mannon; Asif Sharfuddin; Bernard Fischbach; Mohanram Narayanan; Stanley C Jordan; David Cohen; Matthew R Weir; David Hiller; Preethi Prasad; Robert N Woodward; Marica Grskovic; John J Sninsky; James P Yee; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2017-03-09       Impact factor: 10.121

6.  Network Medicine: New Paradigm in the -Omics Era.

Authors:  Nancy Lan Guo
Journal:  Anat Physiol       Date:  2011-12-13

7.  Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC.

Authors:  Travis A Gerke; Neil E Martin; Zhihu Ding; Elizabeth J Nuttall; Edward C Stack; Edward Giovannucci; Rosina T Lis; Meir J Stampfer; Phillip W Kantoff; Giovanni Parmigiani; Massimo Loda; Lorelei A Mucci
Journal:  Prostate       Date:  2015-09-07       Impact factor: 4.104

8.  Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.

Authors:  Ying-Wooi Wan; David G Beer; Nancy Lan Guo
Journal:  Lung Cancer       Date:  2011-11-01       Impact factor: 5.705

9.  A novel network model identified a 13-gene lung cancer prognostic signature.

Authors:  Nancy Lan Guo; Ying-Wooi Wan; Swetha Bose; James Denvir; Michael L Kashon; Michael E Andrew
Journal:  Int J Comput Biol Drug Des       Date:  2011-02-17

10.  Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction.

Authors:  Ying-Wooi Wan; Ebrahim Sabbagh; Rebecca Raese; Yong Qian; Dajie Luo; James Denvir; Val Vallyathan; Vincent Castranova; Nancy Lan Guo
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.